PIRAMAL PHARMA
Back to Cashflow Statement
|
PIRAMAL PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-441 Cr | ₹-422 Cr | ₹818 Cr | ₹794 Cr | ₹3,977 Cr |
What is the latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-441 Cr |
| Mar2024 | ₹-422 Cr |
| Mar2023 | ₹818 Cr |
| Mar2022 | ₹794 Cr |
| Mar2021 | ₹3,977 Cr |
How is Cash Flow from Financing Activities of PIRAMAL PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-441 Cr | Negative | |
| Mar2024 | ₹-422 Cr | Negative | |
| Mar2023 | ₹818 Cr | 2.97 | |
| Mar2022 | ₹794 Cr | -80.03 | |
| Mar2021 | ₹3,977 Cr | - | |
Compare Cash Flow from Financing Activities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹21,141.0 Cr | -5.1% | -10% | -20% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,794.0 Cr | 1.7% | -2.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,956.0 Cr | 2% | -2.2% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,820.0 Cr | -1.8% | -0.1% | 36.7% | Stock Analytics | |
| CIPLA | ₹109,370.0 Cr | -2% | -3.3% | -9.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,133.0 Cr | -0.6% | -3.8% | -6.9% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -5.1% |
-10% |
-20% |
| SENSEX | 1.7% |
2.1% |
-6% |
You may also like the below Video Courses